- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00349245
Dexmedetomidine vs. Remifentanil for Sedation During AFI
A Randomized, Double-Blind Comparison Of Dexmedetomidine And Remifentanil For Sedation During Awake Fiberoptic Intubations
The objective of this study is to determine the efficacy and safety of Dexmedetomidine, a selective alpha-2 adrenoceptor agonist, which has recently gained increased popularity for ICU and intraoperative sedation as a sedative during awake fiberoptic intubation, as compared to Remifentanil.
The hypothesis is that Dexmedetomidine will provide at least equal if not better conditions (sedation and analgesia) required for awake fiberoptic intubation (Ramsay Sedation Scale 3) with less respiratory and cardiovascular adverse effects, as well as less recall than Remifentanil.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Awake nasal or oral fiberoptic intubation remains the method of choice for airway management in the expected difficult airway. This technique requires that a patient be comfortable, relaxed, cooperative and able to maintain their airway with spontaneous ventilation.
In order to achieve these conditions, the pharmacologic agent chosen for sedation should be short acting and highly titratable, provide the required amount of sedation and have little suppression of spontaneous ventilation. There have been numerous reports of the use of Remifentanil and Propofol used either alone or in combination to achieve this level of sedation.
Remifentanil has the following advantages which makes it a useful drug for this purpose:
- Ultra short acting with a constant half life
- Anti-tussive effects which help prevent coughing with tracheal manipulation
- Reversible with an antagonist naloxone
- Attenuates cardiovascular responses to laryngoscopy
Shortcomings of Remifentanil include undesirable side effects, such as hemodynamic instability and respiratory depression.
Dexmedetomidine is a centrally acting, selective alpha-2 agonist which has gained increasing popularity since 1999 as a drug for sedation in ICU settings. It has also been used for intraoperative sedation during surgery under regional anesthesia and for awake craniotomies, as well as for sedation of pediatric patients in different settings. Finally, there are also case reports of Dexmedetomidine being used for awake fiberoptic tracheal intubation.
Theoretically, the pharmacokinetic and pharmacodynamic properties of Dexmedetomidine make it an ideal drug as a single agent for sedation for awake fiberoptic intubation. Venn et al showed that in both healthy individuals and ICU patients, Dexmedetomidine shows a rapid onset and equally rapid distribution half life with quick recovery. This study also demonstrated stable hemodynamics during airway manipulation (extubation) with no adverse cardiovascular or respiratory events during the study.
Other studies have demonstrated that Dexmedetomidine attenuates cardiovascular responses to laryngoscopy and intubation and reduces the need for perioperative opioids. In small doses, it has been demonstrated to have good sedative, amnestic and analgesic effects, as well as anti-sialogogue effects.
Dexmedetomidine does, however, have some drawbacks. In higher bolus doses it can cause hemodynamic changes, such as excessive bradycardia and hypertension followed by hypotension. This drug has also been associated with decreased regional and global cerebral blood flow despite maintenance of MAP within the auto-regulating parameters. These deleterious effects are more prominent in patients with hypovolemia, systemic vasoconstriction, AV block and with rapid bolus infusion.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- Memorial Hermann Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- A signed informed consent must be obtained after the nature of the study has been fully explained.
- Patients undergoing any procedure requiring general anesthesia with an endotracheal tube.
- Patients that have been assessed by an attending anesthesiologist to have an airway requiring awake fiberoptic intubation.
- Adult patients > 18 yrs. old, ASA I - III.
Exclusion Criteria:
Patients expected to have severe adverse side effects to Dexmedetomidine including:
- Previous allergy to the drug.
- 3rd degree AV Block
- Hypovolemic hypotension
- Systemic vasoconstriction
Patients expected to have a severe adverse side effect to Remifentanil. This includes:
- Previous allergy to the drug.
- Patients suspected of being overly sensitive to narcotics.
- Patients with significant cardiovascular disease or ASA physical status IV and V
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Patient's reaction to procedure, as it occurs, ie. grimace, gag, verbalized pain.
Time Frame: duration of intubation
|
duration of intubation
|
Memory recall
Time Frame: post operative, immediately every 30 min for 3 hours and 24 hours
|
post operative, immediately every 30 min for 3 hours and 24 hours
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
NIBP
Time Frame: duration of intubation and first 15 minutes of surgery
|
duration of intubation and first 15 minutes of surgery
|
HR
Time Frame: duration of intubation and first 15 minutes of surgery
|
duration of intubation and first 15 minutes of surgery
|
Cardiac rhythm
Time Frame: duration of surgery
|
duration of surgery
|
Oxygen saturation
Time Frame: duration of intubation and first 15 minutes of surgery
|
duration of intubation and first 15 minutes of surgery
|
End-tidal carbon dioxide
Time Frame: duration of intubation and first 15 minutes of surgery
|
duration of intubation and first 15 minutes of surgery
|
Continuous ECG
Time Frame: duration of intubation and first 15 minutes of surgery
|
duration of intubation and first 15 minutes of surgery
|
Pulse oximetry
Time Frame: duration of intubation and first 15 minutes of surgery
|
duration of intubation and first 15 minutes of surgery
|
Bispectral index
Time Frame: duration of intubation
|
duration of intubation
|
Respiratory rate
Time Frame: duration of intubation and first 15 minutes of surgery
|
duration of intubation and first 15 minutes of surgery
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Carin A Hagberg, M.D., The University of Texas Medical School at Houston
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Adrenergic Agents
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Analgesics, Non-Narcotic
- Adrenergic alpha-2 Receptor Agonists
- Adrenergic alpha-Agonists
- Adrenergic Agonists
- Analgesics, Opioid
- Narcotics
- Hypnotics and Sedatives
- Remifentanil
- Dexmedetomidine
Other Study ID Numbers
- HSC-MS-06-0173
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intubation, Endotracheal
-
The Catholic University of KoreaCompletedEndotracheal Intubation | Individualized Depth of Endotracheal IntubationKorea, Republic of
-
Seoul National University HospitalNot yet recruitingEndotracheal Intubation
-
Mayo ClinicEnrolling by invitation
-
Seoul National University HospitalUnknownEndotracheal IntubationKorea, Republic of
-
Cairo UniversityCompletedEndotracheal Intubation
-
Medical University of WarsawCompleted
-
The University of Texas Health Science Center,...KARL STORZ Endoscopy-America, Inc.CompletedIntubation, EndotrachealUnited States
-
Medical University of WarsawCompleted
-
Lawson Health Research InstituteCompleted
-
Assistance Publique Hopitaux De MarseilleUnknownEndotracheal IntubationFrance
Clinical Trials on Dexmedetomidine
-
Cairo UniversityUnknownSpinal Anesthesia DurationEgypt
-
Guangzhou Women and Children's Medical CenterCompletedAmbulatory Surgical ProceduresChina
-
The First Affiliated Hospital with Nanjing Medical...CompletedPostoperative Pain | Breast Feeding | Analgesia ObstetricalChina
-
Seoul National University Bundang HospitalCompleted
-
Guangzhou General Hospital of Guangzhou Military...CompletedPharmacodynamic InteractionChina
-
University Hospital DubravaRecruitingAortic Valve Stenosis | Systemic Inflammatory ResponseCroatia
-
Guangzhou General Hospital of Guangzhou Military...Completed
-
First Affiliated Hospital, Sun Yat-Sen UniversityUnknownArteriovenous MalformationChina
-
Guangzhou General Hospital of Guangzhou Military...UnknownCombined Spinal-epidural AnesthesiaChina
-
Eye & ENT Hospital of Fudan UniversityCompletedAgitated; State, Acute Reaction to StressChina